145 related articles for article (PubMed ID: 35305186)
1. Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Liu Y; Wang G; Wang H; Zhao X; Chen D; Su X; Yan J; Liang J; Lin J; Zhao K
Clin Rheumatol; 2022 Jul; 41(7):2103-2112. PubMed ID: 35305186
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of
Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
Front Immunol; 2021; 12():745211. PubMed ID: 34867971
[TBL] [Abstract][Full Text] [Related]
3. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
4. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
7. Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study.
Liang J; Cao H; Ke Y; Sun C; Chen W; Lin J
Front Med (Lausanne); 2020; 7():12. PubMed ID: 32083087
[No Abstract] [Full Text] [Related]
8. Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients.
Li Y; Gao X; Li Y; Jia X; Zhang X; Xu Y; Gan Y; Li S; Chen R; He J; Sun X
Front Med (Lausanne); 2020; 7():363. PubMed ID: 32850886
[No Abstract] [Full Text] [Related]
9. FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study.
Kastrati K; Nakuz TS; Kulterer OC; Geßl I; Simader E; Mrak D; Bonelli M; Kiener HP; Prayer F; Prosch H; Aletaha D; Langsteger W; Traub-Weidinger T; Blüml S; Lechner-Radner H; Hacker M; Mandl P
EClinicalMedicine; 2024 Jun; 72():102598. PubMed ID: 38633577
[TBL] [Abstract][Full Text] [Related]
10. Radiological Characteristics of Patients With Anti-MDA5-Antibody-Positive Dermatomyositis in
Cao H; Liang J; Xu D; Liu Y; Yao Y; Sun Y; He Y; Lin J
Front Med (Lausanne); 2021; 8():779272. PubMed ID: 34881270
[No Abstract] [Full Text] [Related]
11. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
14. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
[TBL] [Abstract][Full Text] [Related]
15. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
Bektaş M; Işık EG; Oğuz E; Kemik F; Abbasgholizadeh A; İnce B; Özkan ZG; Yalçınkaya Y; Artım-Esen B; Gül A; İnanç M
Clin Exp Rheumatol; 2024 Feb; 42(2):358-366. PubMed ID: 38293968
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.
Liang J; Cao H; Yang Y; Ke Y; Yu Y; Sun C; Yue L; Lin J
Front Med (Lausanne); 2021; 8():626953. PubMed ID: 33614683
[No Abstract] [Full Text] [Related]
17. Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy.
Liang J; Sun C; Xu L; Xu G; Cao H; Lin J
Rheumatol Ther; 2021 Mar; 8(1):255-272. PubMed ID: 33369709
[TBL] [Abstract][Full Text] [Related]
18. Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive.
Fang X; Zou L; Zhao H; Liu B
Clin Exp Rheumatol; 2024 Feb; 42(2):253-261. PubMed ID: 38293996
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
20. Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review.
Bentick G; Fairley J; Nadesapillai S; Wicks I; Day J
Semin Arthritis Rheum; 2022 Dec; 57():152107. PubMed ID: 36335683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
